Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis.
about
Oligodendrogenesis in the normal and pathological central nervous systemLive imaging of targeted cell ablation in Xenopus: a new model to study demyelination and repair.Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis.From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases.Comparison of MRI signatures in pattern I and II multiple sclerosis models.Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.Evoked potential and behavioral outcomes for experimental autoimmune encephalomyelitis in Lewis ratsModulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain.Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination.Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis.Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration.MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.CatWalk gait analysis in a rat model of multiple sclerosis.Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cellsRemodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis.Demyelinating diseases and potential repair strategies.Remyelination of the central nervous system: a valuable contribution from the periphery.Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental designEffect of MOG sensitization on somatosensory evoked potential in Lewis rats.Dose-dependent anti-inflammatory and neuroprotective effects of an ανβ3 integrin-binding peptide.Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model.Inherited and acquired disorders of myelin: The underlying myelin pathology.Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis.Axonopathy in the Central Nervous System Is the Hallmark of Mice with a Novel Intragenic Null Mutation of DystoninAnticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis.Modulation of neurological deficits and expression of glutamate receptors during experimental autoimmune encephalomyelitis after treatment with selected antagonists of glutamate receptors.Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis.Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect.Co-Transplantation of Human Neurotrophic Factor Secreting Cells and Adipose-Derived Stem Cells in Rat Model of Multiple Sclerosis.Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology.Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models.Blockade of the kinin B1 receptor affects the cytokine/chemokine profile in rat brain subjected to autoimmune encephalomyelitis.Three-dimensional reconstruction of corticospinal tract using one-photon confocal microscopy acquisition allows detection of axonal disruption in spinal cord injury.Axonal pathology and loss precede demyelination and accompany chronic lesions in a spontaneously occurring animal model of multiple sclerosis.Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood-brain barrier damage.Transplantation of human adipose-derived stem cells enhances remyelination in lysolecithin-induced focal demyelination of rat spinal cord.
P2860
Q21129352-D18B4891-A4DB-4B3C-9FBF-A0BB27E549A1Q30525337-056FFE52-A8EA-46D0-8541-60AA10D0AE8EQ31020147-F7DBB931-B628-4648-AAF5-4E0A73E9C971Q31155244-78501D58-96CF-4E36-8A3F-F4CD0CE53667Q33458572-CC4317C8-E964-423B-B2D9-021A02905295Q34499810-0A3BE072-0BBD-431A-A51C-108DF028DBF2Q34562971-612FF74F-178E-4396-B9B8-645C7556AA74Q34576582-4E9AFEA1-8926-41C3-840C-D2C607E0AD85Q34821727-C0262784-042F-4D4C-8FD1-A722E1EBFC5CQ35569899-3736AFAA-02A3-4E91-96ED-7BC4418900A7Q35578626-1D15117A-7A94-4888-923F-26CD10A69DA4Q36095622-C62B1838-9B47-4786-8761-7037DFD146FEQ36154032-DDB54A71-B072-41FF-993D-1C1764868A05Q36208540-4D9D40B9-4EC1-4A9F-80EE-B67C969BFC88Q36333347-4D398B70-AD1E-4156-AC69-F4AC86C7D1A2Q36375008-140E6B6D-813A-4604-A208-E5632F34F0B1Q36399293-8E950880-7FC2-420C-9824-5FECDF81E25CQ36780340-56459442-2FAB-4880-B01F-A340184D9020Q36888602-1C974AD6-72A5-4E41-B6BE-A9AF00A4339AQ36990042-61A94300-9076-44BA-9102-259F5032B166Q37243842-6B17034D-D327-4421-A7C1-0425FE4C4FC2Q37291997-3CB837F2-E191-4572-9C10-DEE7E33AA56FQ37375245-A5D5C47A-DCDF-459A-9C70-1A627FF0CE1CQ37417730-672A51AC-935C-4C82-A9C5-388888F886E5Q38805611-8D1648C4-BF4A-4559-9CB6-3BACB3183468Q41020615-47487684-57BE-4E3A-85D2-9FA2D90DC604Q41021742-AF7CD0CF-60D6-4EAA-820C-A658ECDB2336Q42013348-83F949D7-E1B1-4B02-A8CD-7BC6AE3BAB69Q42071980-133EAB69-BFF2-4065-8BF0-0377DF0200E9Q44325852-D47853ED-69B0-49E8-95B7-7C85B48605E3Q46525864-4A58F1A7-2C71-487F-ACBA-74BE0BD9AF93Q47225588-0D233C67-4E80-4725-BC5F-3B25A3F0682DQ48120862-B5358B77-7176-442E-B2F4-AD36813E2A4DQ48226160-EC10EB48-7A53-4162-9190-E21470994D7AQ48273782-333F4775-3E0F-4343-9160-469C868392B5Q48324890-31E15067-3E9F-4FEF-A611-4B8FC4734DACQ48388500-423D758F-75F2-42EC-8768-B5EA231EBC75Q48452197-3013DAB9-F179-4094-B8A0-799C24B98BDCQ48939776-32CE59BD-D9EF-431A-AFB0-E977217021ABQ50225062-1F89547D-D1C6-44A8-B2F2-F0BE3124CE03
P2860
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Targeting experimental autoimm ...... l model of multiple sclerosis.
@ast
Targeting experimental autoimm ...... l model of multiple sclerosis.
@en
type
label
Targeting experimental autoimm ...... l model of multiple sclerosis.
@ast
Targeting experimental autoimm ...... l model of multiple sclerosis.
@en
prefLabel
Targeting experimental autoimm ...... l model of multiple sclerosis.
@ast
Targeting experimental autoimm ...... l model of multiple sclerosis.
@en
P2093
P2860
P1476
Targeting experimental autoimm ...... l model of multiple sclerosis.
@en
P2093
Bigna S Buddeberg
Christine Stadelmann
Christopher Linington
Daniel C Anthony
Doron Merkler
Florence M Bareyre
Martin E Schwab
Martin Kerschensteiner
Wolfgang Brück
P2860
P304
P356
10.1016/S0002-9440(10)63232-4
P407
P577
2004-04-01T00:00:00Z